Infectious complications of pediatric liver transplantation. 1991

D Saint-Vil, and F I Luks, and P Lebel, and M L Brandt, and K Paradis, and A Weber, and J Guay, and F M Guttman, and A L Bensoussan, and J M Laberge
Department of Surgery, Ste-Justine Hospital, University of Montreal, Quebec, Canada.

Twenty-five pediatric orthotopic liver transplantations (OLTs) performed in 22 patients at Sainte-Justine Hospital were reviewed for infections complications. One patient died within 12 hours posttransplantation and is excluded. The patients had an average age of 6.1 years (range, 1.25 to 19 years) and an average weight of 20.4 kg (range, 11 to 55 kg). Two patients (9%) were cytomegalovirus (CMV) seropositive and 9 of 19 patients (48%) were Epstein-Barr virus (EBV) seropositive preoperatively. Five of the donors (20%) were CMV seropositive. The most common indications for OLT were biliary atresia (8) and tyrosinemia (7). There were 4 deaths, for an overall mortality rate of 19%. In 3 patients, deaths were related to infection (CMV hepatitis and duodenitis with aortoduodenal fistula, adult respiratory distress syndrome [ARDS] with Streptococcus viridans pneumonia, Escherichia coli cholangitis with progressive hepatic failure). Fifteen patients (72%) had 41 major infections, most of them bacterial, during the first month posttransplantation. These include pneumonia (25%), line sepsis (17%), cholangitis (14%), and tracheitis (14%). There was only one major viral infection, a CMV hepatitis that occurred in the first month posttransplantation. Three patients had fungal infections (8%) associated with hepatic artery thrombosis and recurrent cholangitis. All three patients required retransplantation. There was only one protozoal infection (Pneumocystis carinii pneumonia) causing life-threatening respiratory failure, from which patient recovered without sequelae. Infection still remains a serious complication of OLT. Bacterial infection is common and is usually associated with technical complications. The low rate of CMV infection is related to low incidence of CMV in the donor pool and the minimal use of strong immunosuppressants.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007223 Infant A child between 1 and 23 months of age. Infants
D007239 Infections Invasion of the host organism by microorganisms or their toxins or by parasites that can cause pathological conditions or diseases. Infection,Infection and Infestation,Infections and Infestations,Infestation and Infection,Infestations and Infections
D008107 Liver Diseases Pathological processes of the LIVER. Liver Dysfunction,Disease, Liver,Diseases, Liver,Dysfunction, Liver,Dysfunctions, Liver,Liver Disease,Liver Dysfunctions
D008297 Male Males
D011292 Premedication Preliminary administration of a drug preceding a diagnostic, therapeutic, or surgical procedure. The commonest types of premedication are antibiotics (ANTIBIOTIC PROPHYLAXIS) and anti-anxiety agents. It does not include PREANESTHETIC MEDICATION. Premedications
D012086 Reoperation A repeat operation for the same condition in the same patient due to disease progression or recurrence, or as followup to failed previous surgery. Revision, Joint,Revision, Surgical,Surgery, Repeat,Surgical Revision,Repeat Surgery,Revision Surgery,Joint Revision,Revision Surgeries,Surgery, Revision
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug

Related Publications

D Saint-Vil, and F I Luks, and P Lebel, and M L Brandt, and K Paradis, and A Weber, and J Guay, and F M Guttman, and A L Bensoussan, and J M Laberge
February 2010, Pediatric transplantation,
D Saint-Vil, and F I Luks, and P Lebel, and M L Brandt, and K Paradis, and A Weber, and J Guay, and F M Guttman, and A L Bensoussan, and J M Laberge
December 1991, Transplantation proceedings,
D Saint-Vil, and F I Luks, and P Lebel, and M L Brandt, and K Paradis, and A Weber, and J Guay, and F M Guttman, and A L Bensoussan, and J M Laberge
March 1997, Hong Kong medical journal = Xianggang yi xue za zhi,
D Saint-Vil, and F I Luks, and P Lebel, and M L Brandt, and K Paradis, and A Weber, and J Guay, and F M Guttman, and A L Bensoussan, and J M Laberge
January 1994, Annales de radiologie,
D Saint-Vil, and F I Luks, and P Lebel, and M L Brandt, and K Paradis, and A Weber, and J Guay, and F M Guttman, and A L Bensoussan, and J M Laberge
March 1988, Archives of surgery (Chicago, Ill. : 1960),
D Saint-Vil, and F I Luks, and P Lebel, and M L Brandt, and K Paradis, and A Weber, and J Guay, and F M Guttman, and A L Bensoussan, and J M Laberge
November 2015, Gastroenterology & hepatology,
D Saint-Vil, and F I Luks, and P Lebel, and M L Brandt, and K Paradis, and A Weber, and J Guay, and F M Guttman, and A L Bensoussan, and J M Laberge
August 1987, Transplantation proceedings,
D Saint-Vil, and F I Luks, and P Lebel, and M L Brandt, and K Paradis, and A Weber, and J Guay, and F M Guttman, and A L Bensoussan, and J M Laberge
February 2012, Seminars in respiratory and critical care medicine,
D Saint-Vil, and F I Luks, and P Lebel, and M L Brandt, and K Paradis, and A Weber, and J Guay, and F M Guttman, and A L Bensoussan, and J M Laberge
December 2003, Pediatric clinics of North America,
D Saint-Vil, and F I Luks, and P Lebel, and M L Brandt, and K Paradis, and A Weber, and J Guay, and F M Guttman, and A L Bensoussan, and J M Laberge
January 1993, Current clinical topics in infectious diseases,
Copied contents to your clipboard!